Clinical trial / 2019
Vitamin D supplementation in deficient elderly individuals modulated immune markers after influenza vaccination without improving antibody titers.
Elderly individuals with vitamin D deficiency were randomized to receive either 100,000 IU/15 days of cholecalciferol (n = 19) or placebo (n = 19) for 3 months, followed by influenza vaccination and immune evaluation 28 days later. Serum 25-(OH)D increased in the supplementation group (20.7 ± 5.7 to 44.3 ± 8.6 ng/mL, p < 0.001). Supplementation led to lower plasma levels of TNFα (p = 0.040) and IL-6 (p = 0.046), higher TGFβ (p = 0.0028), and a lower Th1/Th2 ratio prior to vaccination (0.12 ± 0.05 vs. 0.18 ± 0.05, p = 0.039). However, no differences were found between groups for antibody titers, serum cathelicidin levels, or ROS production.
- Study type
- Randomized placebo-controlled double-blind trial
- Who was studied
- 38 vitamin D-deficient elderly persons (serum <30 ng/mL)
- What was measured
- Influenza seroprotection, antibody titers, serum cathelicidin, plasma cytokines, lymphocyte phenotyping, phagocyte ROS production
THE PAPER
Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial.
Goncalves-Mendes N, Talvas J, Dualé C, Guttmann A, Corbin V, Marceau G, Sapin V, Brachet P, Evrard B, Laurichesse H, Vasson MP. Front Immunol, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.